HEALTH ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026 Saturday, May 16, 2026 · impact biotech Advertisement Read Original Article → Related Dispatches [US] · Jun 30 Meta Loses Bid to Dismiss US States' Claims That Facebook, Instagram Addict Children [US] · Jun 30 Treasury's Bessent Urges Gas Retailers to Drop Prices for US 250th Birthday, Says 'We're Watching' [US] · Jun 30 Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‐Vec in Ovarian Cancer